Biote Corp (BTMD)
5.88
-0.07
(-1.18%)
USD |
NASDAQ |
May 15, 15:31
Biote Debt to Equity Ratio: -3.150 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -3.150 |
December 31, 2023 | -3.840 |
September 30, 2023 | -2.819 |
June 30, 2023 | -2.491 |
March 31, 2023 | -2.410 |
Date | Value |
---|---|
December 31, 2022 | -2.662 |
September 30, 2022 | -3.220 |
June 30, 2022 | -4.852 |
March 31, 2022 | |
December 31, 2021 | 8.961 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.852
Minimum
Jun 2022
8.961
Maximum
Dec 2021
-1.831
Average
-2.819
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Teladoc Health Inc | 0.6726 |
American Shared Hospital Services | 0.7773 |
Novo Integrated Sciences Inc | 0.1478 |
Astrana Health Inc | 0.5956 |
Cryo-Cell International Inc | -1.019 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 160.11M |
Total Liabilities (Quarterly) | 205.01M |
Shareholders Equity (Quarterly) | -35.40M |
Current Ratio | 4.754 |
Net Debt Paydown Yield | 0.69% |